MedTrace Logo

Ezetimibe and Statins on Postprandial Lipemia in Type 2 Diabetes

NCT00699023 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 13

Last updated 2009-11-04

No results posted yet for this study

Summary

The purpose of this study is to determine whether ezetimibe in association with statins is more effective than statins alone on postprandial lipemia in type 2 diabetic patients.

Conditions

Interventions

DRUG

ezetimibe tablets

ezetimibe tablets 10 mg/die

DRUG

simvastatin tablets

simvastatin tablets 20 mg/die

DRUG

placebo

placebo

Sponsors & Collaborators

  • Federico II University

    lead OTHER

Principal Investigators

  • Gabriele Riccardi, Prof · Department of Clinical and Experimental Medicine, Federico II University Hospital, Naples, Italy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-06-30
Primary Completion
2009-10-31
Completion
2009-10-31

Countries

  • Italy

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00699023 on ClinicalTrials.gov